National Institute of Nursing Research; Notice of Meeting, 49941-49942 [2010-20166]
Download as PDF
Federal Register / Vol. 75, No. 157 / Monday, August 16, 2010 / Notices
sroberts on DSKD5P82C1PROD with NOTICES
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: September 22, 2010.
Open: 8:30 a.m. to 11:45 a.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 3:45 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive,
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892.
(301) 594–8843. stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Digestive Diseases and Nutrition
Subcommittee.
Date: September 22, 2010.
Open: 1:00 p.m. to 1:45 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892.
(301) 594–8843. stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Kidney, Urologic, and Hematologic
Diseases Subcommittee.
Date: September 22, 2010.
Open: 1 p.m. to 2:15 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Closed: 2:15 p.m. to 3:30 p.m.
VerDate Mar<15>2010
18:51 Aug 13, 2010
Jkt 220001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 7, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive,
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892.
(301) 594–8843. stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Diabetes, Endocrinology, and
Metabolic Diseases Subcommittee.
Date: September 22, 2010.
Open: 1:00 p.m. to 2:15 p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 2:15 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, PhD,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
Room 715, MSC 5452, Bethesda, MD 20892.
(301) 594–8843. stanfibr@niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://www.
niddk.nih.gov/fund/divisions/DEA/Council/
coundesc.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–20159 Filed 8–13–10; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
49941
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for Nursing
Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Nursing Research.
Date: September 14–15, 2010
Open: September 14, 2010, 1 p.m. to 5 p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6C, Room 10, Bethesda, MD 20892.
Closed: September 15, 2010, 9 a.m. to 1
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6C, Room 10, Bethesda, MD 20892.
Contact Person: Mary E. Kerr, FAAN, RN,
PhD, Deputy Director, National Institute of
Nursing, National Institutes of Health, 31
Center Drive, Room 5B–05, Bethesda, MD
20892–2178, 301/496–8230,
kerrme@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nih.gov/ninr/a_advisory.html, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
E:\FR\FM\16AUN1.SGM
16AUN1
49942
Federal Register / Vol. 75, No. 157 / Monday, August 16, 2010 / Notices
Dated: August 4, 2010.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–20166 Filed 8–13–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the AIDS
Research Advisory Committee, NIAID.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: AIDS Research
Advisory Committee, NIAID, AIDS Vaccine
Research Subcommittee.
Date: September 21–22, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To discuss updated Vaccine
Enterprise strategic plan and NIAID planned
activities in support of the plan, and plans
for future vaccine clinical research trials and
trial designs.
Place: Crowne Plaza Hotel Rockville, 3
Research Court, Rockville, MD 20850.
Contact Person: James A. Bradac, PhD,
Program Official, Preclinical Research and
Development Branch, Division of AIDS,
Room 5116, National Institutes of Health/
NIAID, 6700B Rockledge Drive, Bethesda,
MD 20892–7628, 301–435–3754,
jbradac@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–20158 Filed 8–13–10; 8:45 am]
BILLING CODE 4140–01–P
sroberts on DSKD5P82C1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Statement of Organization, Functions,
and Delegations of Authority
Part M of the Substance Abuse and
Mental Health Services Administration
VerDate Mar<15>2010
18:51 Aug 13, 2010
Jkt 220001
(SAMHSA) Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services (DHHS) at 73, Number
147, pages 44274–44275, July 30, 2008,
is amended to reflect the new functional
statement for the Office of the
Administrator, the Office of Program
Services, the Office of Applied Studies
and the Office of Policy, Planning and
Budget. In addition this notice
establishes a new Office of Policy,
Planning and Innovation. These changes
are necessary to strengthen cross
Agency collaboration in policy analysis
and development and to streamline
oversight of all financial management
procedures. The changes are as follows:
Section M.20, Functions is amended
as follows:
The functional statement for the
Office of the Administrator is amended
to remove the functions related to
controlled correspondence. The Office
of Program Services is renamed to the
Office of Management, Technology and
Operations. In addition the functions of
grant review, grants management and
contracts management are deleted. The
Office of Applied Studies is renamed to
the Center for Behavioral Health
Statistics and Quality and the Office of
the Director, is amended to remove the
functions related to the Paperwork
Reduction Act. The Office of Policy,
Planning and Budget is renamed the
Office of Financial Resources. In
addition the functions of grant review,
grants management and contracts
management are added and the Division
of Policy Coordination is deleted. The
Office of Policy, Planning and
Innovation is established to provide an
integrated and structured approach for
the identification and adoption of
policies and innovative practices that
improve behavioral health services
outcomes. The functional statement for
each office is changed to read as
follows:
Office of the Administrator (MA)
The Administrator is responsible to
the Secretary for managing and directing
SAMHSA. The office functions are as
follows: (1) Provides leadership in the
development of agency policies and
programs; (2) maintains liaison with the
Office of the Secretary on matters
related to program and other activities;
(3) provides oversight for coordination
between SAMHSA and the National
Institutes of Health (NIH) on the
conduct of research and the
dissemination of research findings in
the areas of alcohol, drug abuse, and
mental health; (4) analyzes legislative
issues, and maintains liaison with
congressional committees; and (5)
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
coordinates Agency communications
and conducts public affairs activities.
Office of Management, Technology and
Operations (MB)
(1) Works in partnership with other
SAMHSA and DHHS components in
managing, providing leadership, and
ensuring SAMHSA’s needs are met in
the following service areas:
administrative services, human
resources management, equal
employment opportunity, organizational
development and analysis, and
information technology; (2) provides
leadership in the development of
policies for and the analysis,
performance measurement, and
improvement of SAMHSA
administrative and management
services; (3) provides leadership,
guidance, and technical expertise for the
Agency’s information technology
program; and (4) provides centralized
administrative services for the Agency.
Center for Behavioral Health Statistics
and Quality (MC)
(1) Collects information as required by
statute on the incidence, prevalence,
trends, correlates of substance abuse
and mental health problems, and the
economic, behavioral and medical
consequences of substance abuse and
mental health problems in the United
States; (2) collects information as
required by statute on the number,
characteristics, conduct, and
performance of facilities and
organizations providing prevention and
treatment services for substance abuse at
the national, State and local level; (3)
plans, directs, and conducts studies
based on data collected by the Center
and other organizations of issues
associated with substance abuse and
mental health problems; (4) designs and
carries out special data collection and
analytic projects to examine topical
issues for SAMHSA and other Federal
agencies; (5) conducts epidemiological,
statistical, and policy studies of existing
or emerging issues; (6) provides
information for program evaluation
activities of the Agency; and (7)
prepares reports and disseminates
findings through Agency publications,
the press, scientific journals, and
electronic systems.
Office of Financial Resources (MG)
(1) Carries out all Chief Financial
Officer functions provided by the Chief
Financial Officers Act of 1990; (2)
represents the agency before the Office
of Management and Budget (OMB) in
matters of presentation of budgets,
performance reporting and resolution of
issues arising from the execution of final
E:\FR\FM\16AUN1.SGM
16AUN1
Agencies
[Federal Register Volume 75, Number 157 (Monday, August 16, 2010)]
[Notices]
[Pages 49941-49942]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-20166]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council for Nursing Research.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Nursing
Research.
Date: September 14-15, 2010
Open: September 14, 2010, 1 p.m. to 5 p.m.
Agenda: Discussion of Program Policies and Issues.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6C, Room 10, Bethesda, MD 20892.
Closed: September 15, 2010, 9 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Conference Room 6C, Room 10, Bethesda, MD 20892.
Contact Person: Mary E. Kerr, FAAN, RN, PhD, Deputy Director,
National Institute of Nursing, National Institutes of Health, 31
Center Drive, Room 5B-05, Bethesda, MD 20892-2178, 301/496-8230,
kerrme@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nih.gov/ninr/a_advisory.html, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.361,
Nursing Research, National Institutes of Health, HHS)
[[Page 49942]]
Dated: August 4, 2010.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-20166 Filed 8-13-10; 8:45 am]
BILLING CODE 4140-01-P